Depression and/or Anxiety and Health-Related Quality of Life Among Adults with Anemia: A National Analysis in the United States.

Depression and/or Anxiety and Health-Related Quality of Life Among Adults with Anemia: A National Analysis in the United States

Background: Anemia frequently coexists with depression and anxiety, which may further compromise health-related quality of life (HRQoL). However, limited evidence exists on the independent association of these mental health comorbidities with physical and mental HRQoL among adults with anemia. The study objective is to examine the association between coexisting depression and/or anxiety and HRQoL among adults with anemia in the United States. Methods: A cross-sectional study was conducted among 835 adults with anemia. Participants were categorized into two groups: anemia only and anemia with depression and/or anxiety. HRQoL was assessed using the Physical Component Summary (PCS) and Mental Component Summary (MCS) scores of the Veterans RAND 12-Item Health Survey (VR-12©). Weighted descriptive statistics were used to characterize the study population, and differences between groups were evaluated using chi-square tests and t-tests. Multivariable linear regression analyses were performed to examine the association between the anemia groups and HRQoL after adjusting for sociodemographic characteristics, health insurance, general health status, physical activity, and chronic comorbidities. Results: Among the adults with anemia, 69.3% had anemia only and 30.7% had anemia with depression and/or anxiety. Participants with depression and/or anxiety had significantly lower mean PCS (39.61 vs. 42.78, p < 0.0001) and MCS (44.24 vs. 52.49, p < 0.0001) scores than those with anemia alone. In adjusted analyses, coexisting depression and/or anxiety was independently associated with significantly lower MCS scores (β = −7.09, SE = 0.91, p < 0.001) but was not associated with PCS (β = 1.04, SE = 1.00, p > 0.05). Poor self-rated health was strongly associated with lower PCS and MCS scores, while younger age, employment, and regular physical activity were associated with better physical HRQoL. Conclusions: Among adults with anemia, coexisting depression and/or anxiety was independently associated with substantially poorer mental health-related quality of life, but not with physical health-related quality of life after adjustment for sociodemographic characteristics, healthcare access, health status, physical activity, and chronic comorbidities. These findings highlight the importance of recognizing and addressing coexisting mental health conditions in adults with anemia as part of comprehensive, patient-centered care.

1. Introduction

Anemia is one of the most common hematological disorders worldwide and remains a major public health concern affecting individuals across all age groups. It is characterized by a reduced hemoglobin concentration or red blood cell mass, resulting in impaired oxygen delivery to tissues and organs [1]. Worldwide, anemia impacts about 24.8% of the total population [2]. In the United States, anemia affects millions of adults, particularly older individuals, women, and those with chronic medical conditions [3,4]. Beyond its hematologic manifestations, anemia is associated with fatigue, weakness, reduced physical functioning, disability, productivity loss, impaired cognitive performance, increased healthcare utilization, and higher mortality, imposing a substantial clinical and economic burden on patients and healthcare systems [5,6,7,8].

The consequences of anemia extend beyond physical symptoms. Individuals with anemia frequently experience psychological distress, including depression and anxiety, which may arise from persistent fatigue, functional limitations, chronic illness, and reduced social participation [5,9,10,11,12,13]. This relationship is likely bidirectional, as depression and anxiety may both contribute to and result from anemia [14,15]. Conversely, depression and anxiety may exacerbate the burden of anemia by impairing treatment adherence, reducing self-care behaviors, increasing symptom perception, and adversely affecting health outcomes (e.g., symptom burden, functional status, and health-related quality of life) [16]. The coexistence of anemia with common mental health disorders therefore represents an important but often under-recognized clinical challenge that may adversely affect patients’ well-being.

These interrelated physical and psychological burdens may ultimately have important consequences for patients’ overall well-being, making quality of life a particularly relevant patient-centered outcome. Health-related quality of life (HRQoL) captures the impact of disease on physical, psychological, and social functioning [17]. It has become an increasingly important endpoint in clinical research because it reflects the patient’s perception of health beyond traditional clinical and laboratory measures. Previous studies have consistently shown that anemia is associated with poorer HRQoL across diverse national populations from Netherlands and Italy [7,18,19,20], while depression and anxiety independently contribute to substantial reductions in both physical and mental functioning [21]. Among adults with anemia in the United States, approximately 20.0–27.0% had depression and 6.0 to 7.0% had anxiety disorder [22]. Globally, studies have reported that depression affects approximately 23% of adults with anemia. Yet, these mental health conditions remain under-recognized and undertreated among individuals with anemia.

Although depression/anxiety has each been associated with poorer HRQoL in anemic patients, relatively little is known about their combined impact among adults with anemia in the general United States population. Previous studies have primarily examined the association between anemia and HRQoL rather than evaluating the additional impact of coexisting depression and/or anxiety on HRQoL among adults with anemia [18]. Moreover, much of the available evidence has focused on the elderly, above 65 years or older [19,20]. Consequently, the extent to which coexisting depression and/or anxiety are independently associated with physical and mental HRQoL among adults with anemia remains insufficiently understood. Addressing this gap may provide clinically relevant evidence to identify adults with anemia who are at greater risk of impaired HRQoL and support a more comprehensive approach to anemia care. In particular, understanding the contribution of depression and anxiety may inform psychological screening, integrated physical and mental health management, and patient-centered interventions aimed at improving quality of life and overall well-being. Therefore, the objective of this study was to examine the association between coexisting depression and/or anxiety and health-related quality of life among adults with anemia in the United States using nationally representative data from the Medical Expenditure Panel Survey (MEPS). We hypothesized that adults with anemia and coexisting depression and/or anxiety would report significantly poorer physical and mental HRQoL than those with anemia alone. To our knowledge, this is among the first nationally representative United States studies to quantify the independent association of coexisting depression and/or anxiety with both physical and mental HRQoL among adults with anemia while comprehensively adjusting for sociodemographic characteristics, healthcare access, physical activity, and multiple chronic conditions.

2. Methods

2.1. Study Design and Data

This retrospective cross-sectional study utilized data from the 2017–2022 panels of the Medical Expenditure Panel Survey (MEPS), a nationally representative survey of the United States civilian noninstitutionalized population conducted by the Agency for Healthcare Research and Quality (AHRQ). MEPS employ a stratified, multistage probability sampling design and follows participants over two consecutive years through multiple rounds of computer-assisted personal interviews [23]. The survey collects detailed information on demographic and socioeconomic characteristics, chronic medical conditions, healthcare utilization and expenditure, health insurance coverage, income, and employment. Participants self-report their medical conditions during interviews, and these conditions are subsequently coded into standardized International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes.

2.2. Study Population

Participants were included if they were adults, defined as individuals aged 18 years or older; had a documented diagnosis of anemia; were alive during the study period; and had complete health-related quality of life (HRQoL) data. Participants were excluded from the analytic sample if they were younger than 18 years; did not have a documented diagnosis of anemia; were not alive during the study period; or had missing or incomplete HRQoL information. Anemia was identified in the Medical Expenditure Panel Survey (MEPS) using the ICD-10-CM diagnosis codes D50 (Iron deficiency anemia) and D64 (Other anemia), which are the anemia diagnoses available in the MEPS public-use files.

2.3. Measures

2.3.1. Outcome: Health-Related Quality of Life (HRQoL)

Health-related quality of life (HRQoL) was assessed using the Veterans RAND 12-Item Health Survey (VR-12®), a validated and widely used patient-reported outcome measure administered as part of the Medical Expenditure Panel Survey (MEPS) [24,25]. The VR-12® was developed and validated for use among United States veterans and subsequently evaluated for use in the broader adult population. The VR-12 instrument contains 12 items, which represent eight health domains, including general health, physical functioning, role limitations due to physical health, bodily pain, vitality, role limitations due to emotional problems, mental health, and social functioning. Responses to these domains are summarized into two standardized composite measures: the Physical Component Summary (PCS), which reflects physical health status based on general health, physical functioning, role limitations due to physical health, and bodily pain; and the Mental Component Summary (MCS), which assesses mental health through vitality, role limitations due to emotional problems, mental health, and social functioning. Higher PCS and MCS scores indicate better health-related quality of life [26]. Both PCS and MCS showed high internal consistency (α > 0.80). Test–retest reliability was high for PCS (ICC = 0.78) and moderate for MCS (ICC = 0.60). PCS showed strong convergent validity, while MCS demonstrated moderate convergent validity with EQ-5D and mental health measures [26].

2.3.2. Independent Variables

Depression and anxiety were identified based on the corresponding ICD-10-CM diagnostic codes recorded in the MEPS. Participants with anemia were categorized into two mutually exclusive study groups according to the presence or absence of a documented diagnosis of depression and/or anxiety. The depression and/or anxiety group included participants with a documented diagnosis of depression, anxiety, or both (anemia with coexisting depression and/or anxiety), whereas the anemia-only group included participants with anemia who had no documented diagnosis of either depression or anxiety (anemia only). Additional covariates were selected based on established evidence of their association with HRQoL among adults with anemia. These included sociodemographic characteristics (age, sex, race/ethnicity, education level, marital status, employment status, poverty status, and region of residence). Health insurance and prescription drug insurance coverage were included as indicators of healthcare access, which may influence HRQoL. Self-rated general health and physical activity were also considered because of their known associations with physical and mental well-being. Furthermore, chronic comorbidities, including heart disease, hypertension, diabetes, hyperlipidemia, asthma, chronic obstructive pulmonary disease (COPD), arthritis, gastroesophageal reflux disease (GERD), and cancer, were included in the analyses and were identified using the ICD-10-CM diagnostic codes recorded in the MEPS.

2.4. Statistical Analyses

Descriptive statistics were used to summarize the baseline characteristics of adults with anemia, including means, standard deviations, frequencies, and weighted percentages. PROC SURVEYFREQ was used to estimate weighted frequencies and percentages for categorical variables; PROC SURVEYMEANS was used to estimate weighted means and standard deviations for continuous variables. Chi-square tests were used to assess differences between the two anemia groups (anemia only vs. anemia with depression and/or anxiety) for categorical participant characteristics, including sociodemographic variables, health insurance, self-rated general health, physical activity, and chronic comorbidities. Differences in mean health-related quality of life (HRQoL) scores, including the Physical Component Summary (PCS) and Mental Component Summary (MCS), were evaluated using independent sample t-tests. Prior to conducting the multiple linear regression analyses, model assumptions were assessed. Linearity was evaluated by examining the relationship between the predictors and the outcome, while independence of observations was considered based on the study design. Multicollinearity was assessed using variance inflation factors (VIFs) and tolerance values. Homoscedasticity was evaluated by examining the residuals versus fitted values, and the distribution of residuals was assessed using diagnostic plots. No substantial violations of the regression assumptions were identified. Multivariable linear regression models were then fitted to examine the association between anemia group and HRQoL. Two separate multivariable linear regression models were fitted: with PCS score as the dependent variable in the first model and with MCS score as the dependent variable in the second model. The primary independent variable was anemia group, comparing participants with anemia and coexisting depression and/or anxiety with those with anemia alone. Covariates included sociodemographic characteristics, healthcare access variables, general health status, physical activity, and chronic comorbidities. PROC SURVEYREG was used to perform multivariable linear regression analyses. The general model can be expressed as HRQoLi = β0 + β1(Anemia group)i + β2(Sociodemographic characteristics)i + β3(Healthcare access)i + β4(Health status)i + β5(Physical activity)i + β6(Comorbidities)i + εi; where HRQoL represents either PCS or MCS. Statistical significance was assessed using a two-sided α = 0.05 threshold for the chi-square tests, independent-samples t-tests, and regression analyses. All analyses accounted for the complex sampling design of the Medical Expenditure Panel Survey (MEPS) by incorporating person-level sampling weights, strata, and primary sampling units to generate nationally representative estimates. Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC, USA; released in 2023).

3. Results

3.1. Characteristics of the Study Sample

A total of 835 adults with anemia were included in the analysis (Table 1). Of these, 567 participants (69.3%) had anemia alone, while 268 participants (30.7%) had anemia with coexisting depression and/or anxiety.

There were no statistically significant differences between the anemia groups according to age (p = 0.250), sex (p = 0.164), marital status (p = 0.148), education level (p = 0.248), region of residence (p = 0.194), employment status (p = 0.075), poverty status (p = 0.594), physical activity (p = 0.191), heart disease (p = 0.089), hypertension (p = 0.087), or diabetes (p = 0.550).

Significant differences were observed across racial/ethnic groups (p < 0.0001). White participants had the highest proportion of anemia with depression and/or anxiety (37.0%), compared with Latino (26.2%), African American (16.8%), and participants of other races/ethnicities (18.2%). Health insurance status differed significantly between the groups (p = 0.008). Participants with public insurance had a higher prevalence of anemia with depression and/or anxiety (37.6%) than those with private insurance (26.6%) or who were uninsured (26.8%). Similarly, individuals without prescription drug insurance were more likely to have anemia with depression and/or anxiety than those with prescription coverage (35.1% vs. 25.9%, p = 0.007).

General health status was strongly associated with anemia group (p < 0.0001). The proportion of participants with anemia and depression and/or anxiety increased progressively with worsening self-rated health, from 22.6% among those reporting excellent/very good health to 29.2% among those reporting good health and 40.2% among those reporting fair/poor health. Several chronic conditions were significantly more common among participants with anemia and depression and/or anxiety than among those with anemia alone. These included hyperlipidemia (36.2% vs. 27.8%, p = 0.038), asthma (45.9% vs. 28.4%, p = 0.001), COPD (46.1% vs. 29.5%, p = 0.025), arthritis (46.0% vs. 27.1%, p < 0.0001), GERD (39.7% vs. 28.2%, p = 0.006), and cancer (41.7% vs. 29.3%, p = 0.030). In contrast, no significant differences were observed for heart disease, hypertension, or diabetes.

3.2. Health-Related Quality of Life Scores by Anemia Groups

Table 2 presents the weighted mean health-related quality of life (HRQoL) scores among adults with anemia according to anemia group. Overall, the study sample had a mean Physical Component Summary (PCS) score of 40.43 (SD = 13.14) and a mean Mental Component Summary (MCS) score of 48.78 (SD = 10.90).

Participants with anemia only had significantly higher HRQoL scores than those with anemia and depression and/or anxiety. The mean PCS score was 42.78 (SE = 0.71) among participants with anemia only compared with 39.61 (SE = 0.98) among those with anemia and depression and/or anxiety (p < 0.0001). Similarly, the mean MCS score was substantially higher in the anemia-only group (52.49, SE = 0.36) than in the anemia with depression and/or anxiety group (44.24, SE = 0.85; p < 0.0001).

3.3. Factors Associated with Health-Related Quality of Life

Table 3 presents the adjusted multivariable linear regression analyses examining the association between anemia group and health-related quality of life (HRQoL), measured by the Physical Component Summary (PCS) and Mental Component Summary (MCS) scores. The regression coefficient (β) represents the adjusted mean difference in the HRQoL score associated with each predictor, relative to its reference category, while holding the other covariates constant (i.e., sociodemographic characteristics, health insurance, health status, physical activity, and chronic conditions).

After adjustment, anemia with depression and/or anxiety was not significantly associated with PCS (β = 1.041, SE = 1.000), but it was independently associated with a 7.09-point lower MCS score compared with anemia alone (β = −7.089, SE = 0.905, p < 0.001), indicating a substantial negative association with mental HRQoL.

Younger age was significantly associated with better physical health. Compared with adults aged >64 years, participants aged 22–39 years had PCS scores approximately 7.45 points higher (β = 7.450, SE = 1.621, p < 0.001), while those aged 40–49 years had PCS scores approximately 5.65 points higher (β = 5.651, SE = 1.546, p < 0.001), whereas age was not significantly associated with MCS. Sex, race/ethnicity, marital status, education, health insurance, prescription drug insurance, and most chronic conditions were not independently associated with either PCS or MCS.

Participants residing in the Midwest had significantly higher PCS scores than those living in the West (β = 2.553, SE = 1.170, p < 0.05). Employed participants had PCS scores approximately 3.71 points higher than those who were not employed (β = 3.709, SE = 1.154, p < 0.01). Poverty status was associated only with mental health, as participants with near-poor (β = 4.290, SE = 1.392, p < 0.01) and middle-income status (β = 4.241, SE = 1.239, p < 0.001) had MCS scores that were nearly 4 points higher than that of those living in poverty.

Self-rated general health was one of the strongest predictors of HRQoL. Compared with participants reporting good health, those reporting excellent or very good health had 4-point higher PCS scores (β = 4.008, SE = 1.024, p < 0.001), conversely, participants reporting fair/poor health had substantially lower HRQoL scores, 8.86-point lower PCS scores (β = −8.861, SE = 1.056, p < 0.001) and 6.87-point lower MCS scores (β = −6.870, SE = 0.936, p < 0.001), than those reporting good health. In addition, engaging in physical activity at least three times per week led to 2.61-point higher PCS scores (β = 2.612, SE = 0.881, p < 0.01). Among the chronic conditions examined, GERD was associated with a nearly 2-point lower physical health score (β = −2.365, SE = 1.180, p < 0.05). No significant associations were observed for heart disease, hypertension, diabetes, hyperlipidemia, asthma, COPD, cancer or arthritis after adjustment.

4. Discussion

4.1. Prevalence and Comorbidity of Depression and Anxiety

This study examined the association between coexisting depression and/or anxiety and health-related quality of life (HRQoL) among adults with anemia in the United States. Approximately one-third of adults with anemia also had depression and/or anxiety, highlighting the substantial burden of mental health conditions in this population. This finding is consistent with previous studies conducted both globally and in the United States, which have reported a high prevalence of depression and anxiety among individuals with anemia [10,13,16,27]. Individuals with both anemia and depression and/or anxiety reported poorer self-rated health and a higher prevalence of several chronic conditions, including hyperlipidemia, asthma, chronic obstructive pulmonary disease (COPD), arthritis, gastroesophageal reflux disease (GERD), and cancer. The higher prevalence of several chronic conditions and poorer self-rated health among participants with depression and/or anxiety suggests that these individuals may experience a greater overall burden of illness. The coexistence of multiple physical and mental health conditions may increase symptom burden, functional limitations, and healthcare needs, which may in turn contribute to poorer perceived health and HRQoL. This pattern is consistent with previous research showing that these chronic conditions commonly coexist with anemia and contribute to a greater overall disease burden [28,29].

4.2. Depression and Anxiety Are Associated with Poorer Mental HRQoL

The most notable finding was that, after adjustment for sociodemographic characteristics, insurance status, general health, physical activity, and chronic conditions, depression and/or anxiety remained independently associated with substantially poorer mental HRQoL but not physical HRQoL. Participants with depression and/or anxiety had MCS scores that were more than seven points lower than that of those with anemia alone, suggesting a clinically meaningful impairment in mental well-being. This association may reflect the direct influence of depression and anxiety on emotional functioning, mood, perceived well-being, and the ability to cope with the demands of living with a chronic condition such as anemia. Symptoms such as fatigue, reduced energy, sleep disturbances, and impaired concentration may also overlap with manifestations of both anemia and depression and anxiety, potentially increasing the overall psychological burden.

This finding underscores the considerable psychological burden experienced by adults living with anemia and highlights the importance of addressing mental health alongside the management of anemia. Our findings are further supported by evidence from a large meta-analysis showing that treatment of anemia with erythropoiesis-stimulating agents significantly improved HRQoL in patients with cancer- and chronic kidney disease-related anemia, with greater improvements in hematocrit associated with greater gains in quality of life [30]. Together, these findings emphasize that optimizing anemia management while addressing coexisting mental health conditions may be essential for improving overall patient well-being.

Our findings are consistent with evidence summarized in a recent review, which reported that treatment of iron deficiency anemia may improve several psychiatric symptoms, including depressed mood, fatigue, anxiety, anhedonia, and sleep disturbances [31]. The review also highlighted that the overlap between symptoms of iron deficiency and depression may contribute to misdiagnosis in some patients [21]. In addition, it suggested that correction of iron deficiency may enhance the effectiveness of antidepressant therapy when iron supplementation is used alongside standard treatment. These observations underscore the importance of considering iron deficiency in the evaluation of patients presenting with depressive symptoms and support an integrated approach to managing anemia and coexisting mental health conditions.

4.3. Factors Associated with Physical and Mental HRQoL

The strong association between self-rated health and both PCS and MCS is particularly important. Self-rated health may capture the cumulative effects of symptoms, functional limitations, chronic disease burden, and an individual’s overall perception of their health that may not be fully represented by individual clinical conditions. Moreover, employed participants had higher PCS scores than those who were not employed. This association may reflect better functional capacity, fewer physical limitations, or greater social engagement among individuals who remain employed. Regular physical activity was also associated with higher PCS scores. Although physical activity may contribute to better physical functioning, it may also serve as a marker of better underlying health, and the cross-sectional design prevents determination of the direction of this association.

Participants with depression and/or anxiety had a higher prevalence of several chronic conditions, including hyperlipidemia, asthma, chronic obstructive pulmonary disease (COPD), arthritis, gastroesophageal reflux disease (GERD), and cancer. The accumulation of multiple chronic conditions may increase symptom burden, functional limitations, medication burden, healthcare needs, and the challenges associated with self-management. These factors may contribute to poorer perceived health and lower HRQoL among individuals simultaneously managing anemia and mental health conditions.

The observed pattern may also reflect a bidirectional relationship between mental and physical health. Persistent physical symptoms and limitations associated with chronic diseases may contribute to psychological distress, while depression and anxiety may affect symptom perception, treatment adherence, physical activity, and self-management. However, the present cross-sectional analysis cannot establish the direction of these relationships. Therefore, the observed coexistence of mental health conditions, anemia, and chronic diseases should be interpreted as an indicator of a higher overall burden of illness rather than as evidence of a causal pathway.

Collectively, these findings support a biopsychosocial model of anemia management in which psychological well-being, social determinants of health, and chronic disease burden should be considered alongside hematologic treatment. Addressing anemia alone may not be sufficient to improve patients’ overall quality of life if coexisting mental health conditions remain unidentified and untreated.

4.4. Clinical and Policy Implications

The findings have several important clinical and public health implications. First, routine screening for depression and anxiety should be incorporated into the clinical assessment of adults with anemia, particularly among those reporting poor general health or multiple chronic conditions. Early identification of psychological distress may facilitate timely referral for mental health evaluation and treatment.

Second, integrated models of care involving primary care physicians, hematologists, mental health professionals, and pharmacists may improve overall patient outcomes by addressing both the physical and psychological consequences of anemia. Collaborative care approaches have demonstrated benefits in other chronic diseases and may similarly improve quality of life among individuals with anemia.

Third, interventions promoting physical activity, employment support, chronic disease management, and patient self-management may improve physical functioning, while psychological counseling and behavioral interventions may specifically enhance mental HRQoL. Policymakers should also consider improving access to mental health services and prescription drug coverage for vulnerable populations with anemia, particularly those insured through public programs or with limited healthcare resources.

Future longitudinal studies are needed to clarify the temporal relationship between anemia, depression, anxiety, and HRQoL and to determine whether treatment of mental health conditions improves long-term patient-reported outcomes among adults with anemia.

4.5. Strengths and Limitations

This study has several strengths. It utilized a large, nationally representative sample of adults with anemia in the United States, allowing the findings to be generalized to the noninstitutionalized adult population. The use of survey weights and complex sampling methods enhances the representativeness of the estimates. In addition, HRQoL was measured using the validated Veterans RAND 12-Item Physical and Mental Component Summary scores, and the analyses accounted for a broad range of sociodemographic, health-related, and clinical covariates, reducing the likelihood of confounding.

Despite these strengths, several limitations should be considered. First, the cross-sectional design precludes establishing causal relationships between depression, anxiety, anemia, and HRQoL. It is not possible to determine whether depression and anxiety contributed to poorer quality of life or whether poorer quality of life increased the likelihood of psychological distress. Second, diagnoses of anemia, depression, anxiety, and chronic conditions were based on self-reported information and may be subject to recall or reporting bias. Third, the dataset did not include information on anemia severity, laboratory parameters (e.g., hemoglobin levels, ferritin concentrations), anemia subtype, treatment status, or duration of illness, all of which may influence quality of life. Fourth, residual confounding from unmeasured variables, including social support, health behaviors, medication adherence, symptom severity, and access to mental healthcare, cannot be excluded. Finally, the study focused on adults with anemia in the United States; therefore, the findings may not be directly generalizable to healthcare systems or populations in other countries.

5. Conclusions

Among adults with anemia in the United States, nearly one-third had coexisting depression and/or anxiety. After adjustment, coexisting depression and/or anxiety was independently associated with significantly poorer mental HRQoL but not physical HRQoL. These findings highlight the substantial mental health burden among adults with anemia and underscore the importance of recognizing and addressing coexisting depression and anxiety as part of comprehensive, patient-centered care. Future longitudinal and intervention studies are warranted to determine whether effective management of depression and anxiety, together with optimal anemia treatment, can improve HRQoL. These findings indicate that psychological comorbidity represents an important dimension of the overall burden experienced by adults with anemia. Routine screening for depression and anxiety, timely referral for appropriate psychological care, and integration of mental health services into anemia management may help address unmet patient needs and improve patient-centered outcomes. Future longitudinal and intervention studies are warranted to determine whether effective management of depression and anxiety, together with optimal anemia treatment, can improve HRQoL and reduce the risk of persistent or recurrent psychological distress.

References

1.Suprapti E. Hadju V. Ibrahim E. Indriasari R. Erika K.A. Balqis B. Anemia: Etiology, Pathophysiology, Impact, and Prevention: A Review Iran. J. Public Health 2025 54 509 520 10.18502/ijph.v54i3.18244 PMC12051798 40330196

2.Luo W. Sun H. Cao H. Zhou G. Luo Y. Global, regional, and national burden of anemia, 1990 to 2021: An observational study analysis for the global burden of disease Medicine 2025 104 e44380 10.1097/md.0000000000044380 40988239 PMC12459588

3.Shwarz M. Burden of anemia in the United States from 1990 to 2019: A systematic analysis of the Global Burden of Disease Study 2019 Front. Public Health 2025 13 165322210.3389/fpubh.2025.1653222 41112644 PMC12532043

4.Lee S. Son Y. Hwang J. Kim M.S. Il Shin J. Yon D.K. Kassebaum N.J. GBD 2021 Dietary Iron Deficiency CollaboratorsGlobal, regional and national burden of dietary iron deficiency from 1990 to 2021: A Global Burden of Disease study Nat. Med. 2025 31 1809 1829 10.1038/s41591-025-03624-8 40263631

5.Maraldi C. Ble A. Zuliani G. Guralnik J.M. Mussi C. Fellin R. Volpato S. Association between anemia and physical disability in older patients: Role of comorbidity Aging Clin. Exp. Res. 2006 18 485 492 10.1007/bf03324848 17255637

6.Warner M.A. Weyand A.C. The Global Burden of Anemia Blood Substitutes and Oxygen Biotherapeutics Liu H. Kaye A.D. Jahr J.S. Springer International PublishingCham, Switzerland2022 53 59

7.Takeshima T. Yamamoto Y. Iwasaki K. Ha C. Oishi M. Sato A. Sonoyama Y. Honda N. Niida H. Takeda J. Prevalence, treatment status, medical costs, quality of life, and productivity loss in Japanese adult patients with anemia: A real-world database study J. Med. Econ. 2023 26 1386 1397 10.1080/13696998.2023.2271752 37849298

8.Huang S. Li H. Zhang L. Chen H. Gao C. Global Burden of Diseases Associated with Iron Deficiency: GBD 2021 Int. J. Vitam. Nutr. Res. 2025 95 31351 10.31083/ijvnr31351 40613395

9.Park G.N. Kim J.O. Oh J.W. Lee S. Association between anemia and depression: The 2014, 2016, and 2018 Korea National Health and Nutrition Examination Survey J. Affect. Disord. 2022 312 86 91 10.1016/j.jad.2022.06.015 35750091

10.Lee Y.-J. Kim H.-B. Association between anaemia and adult depression: A systematic review and meta-analysis of observational studies J. Epidemiol. Community Health 2020 74 565 572 10.1136/jech-2020-213842 32291287

11.Forbes M. Mohebbi M. Lotfaliany M. Woods R.L. Vidanagama N. Reynolds C.F. IIIO’NEil A. McNeil J.J. Berk M. Anemia and Depression in Older Adults: A Longitudinal Cohort Study Am. J. Geriatr. Psychiatry Open Sci. Educ. Pract. 2024 4 18 27 10.1016/j.osep.2024.09.002

12.Zamani S. Abed M. Amini A. Ghorbanpour A. Examining the General Health and Mental Health of Individuals with Iron-Deficiency Anemia Int. J. Psychiatry Med. 2025 61 631 649 10.1177/00912174251382660 41045038

13.Yu C. Hardoy C.R. Paulino M.T. Vikram E.P. Giffin J.F. Aledia A.S. Bera R. Amin A.N. Demographic predictors of major depressive disorder among patients with iron deficiency anemia: A retrospective cross-sectional observational study BMC Psychiatry 2026 10.1186/s12888-026-08389-z 42477598 PMC13679099

14.Liu C. Zhou R. Peng X. Zhu T. Wei W. Hao X. Relationship between depressive symptoms and anemia among the middle-aged and elderly: A cohort study over 4-year period BMC Psychiatry 2023 23 57210.1186/s12888-023-05047-6 37553590 PMC10408197

15.Petrova M.M. Shimokhina N.Y. Suvorova A.A. The relationship between anemia and cognitive and anxiety-depressive disorders: A review Cons. Medicum 2026 28 113 118 10.26442/20751753.2026.2.203554

16.Onukogu C.U. Daniel F.M. Essien E.A. Winter-Eteng B.F. Nkangha D.D. Psychosocial challenges of persons with sickle cell anemia: A narrative review Medicine 2023 102 e36147 10.1097/md.0000000000036147 38013366 PMC10681612

17.Karimi M. Brazier J. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? Pharmacoeconomics 2016 34 645 649 10.1007/s40273-016-0389-9 26892973

18.Wouters H. van der Klauw M.M. de Witte T. Stauder R. Swinkels D.W. Wolffenbuttel B.H.R. Huls G. Association of anemia with health-related quality of life and survival: A large population-based cohort study Haematologica 2019 104 468 476 10.3324/haematol.2018.195552 30309850 PMC6395328

19.Thein M. Ershler W.B. Artz A.S. Tecson J. Robinson B.E. Rothstein G. Liede A. Gylys-Colwell I. Lu Z.J. Robbins S. Diminished Quality of Life and Physical Function in Community-Dwelling Elderly with Anemia Medicine 2009 88 107 114 10.1097/md.0b013e31819d89d5 19282701 PMC2893336

20.Lucca U. Tettamanti M. Mosconi P. Apolone G. Gandini F. Nobili A. Tallone M.V. Detoma P. Giacomin A. Clerico M. Association of mild anemia with cognitive, functional, mood and quality of life outcomes in the elderly: The “Health and Anemia” study PLoS ONE 2008 3 e192010.1371/journal.pone.0001920 18382689 PMC2271152

21.Levenson J.L. McClish D.K. Dahman B.A. Bovbjerg V.E. Citero V.d.A. Penberthy L.T. Aisiku I.P.M. Roberts J.D. Roseff S.D. Smith W.R. Depression and anxiety in adults with sickle cell disease: The PiSCES project Psychosom. Med. 2008 70 192 196 10.1097/psy.0b013e31815ff5c5 18158366

22.Thomas D.R. Anemia and Quality of Life: Unrecognized and Undertreated J. Gerontol. Ser. A 2004 59 M238 M241 10.1093/gerona/59.3.m238 15031307

23.Quality AfHRaMedical Expenditure Panel Survey (MEPS) HC 243 2022 Full Year Consolidated Data File Available online: https://meps.ahrq.gov/mepsweb/data_stats/download_data/pufs/h243/h243doc.pdf(accessed on 12 August 2026)

24.Selim A.J. Rothendler J.A. Qian S.X. Bailey H.M. Kazis L.E. The History and Applications of the Veterans RAND 12-Item Health Survey (VR-12) J. Ambul. Care Manag. 2022 45 161 170 10.1097/jac.0000000000000420 35612387

25.Kazis L.E. Rogers W.H. Rothendler J. Qian S. Selim A. Edelen M.O. Stucky B.D. Rose A.J. Butcher E. Outcome Performance Measure Development for Persons with Multiple Chronic Conditions RAND CorporationSanta Monica, CA, USA2017

26.Cheak-Zamora N.C. Wyrwich K.W. McBride T.D. Reliability and validity of the SF-12v2 in the medical expenditure panel survey Qual. Life Res. 2009 18 727 735 10.1007/s11136-009-9483-1 19424821

27.Gupta B. Goel R. Satodiya V. Gupta K. Mittal A. Association of Anaemia and Depression: A Systematic Review and Meta-analysis Niger. Med. J. 2025 66 1486 1509 41472978 10.71480/nmj.v66i4.959 PMC12746323

28.Gandhi S.J. Hagans I. Nathan K. Hunter K. Roy S. Prevalence, Comorbidity and Investigation of Anemia in the Primary Care Office J. Clin. Med. Res. 2017 9 970 980 10.14740/jocmr3221w 29163729 PMC5687900

29.Zaninetti C. Klersy C. Scavariello C. Bastia R. Balduini C.L. Invernizzi R. Prevalence of anemia in hospitalized internal medicine patients: Correlations with comorbidities and length of hospital stay Eur. J. Intern. Med. 2018 51 11 17 10.1016/j.ejim.2017.11.001 29153343

30.Ross S.D. Fahrbach K. Frame D. Scheye R. Connelly J.E. Glaspy J. The effect of anemia treatment on selected health-related quality-of-life domains: A systematic review Clin. Ther. 2003 25 1786 1805 10.1016/s0149-2918(03)80170-4 12860499

31.Arshad H. Arshad A. Hafiz M.Y. Muhammad G. Khatri S. Arain F. Psychiatric Manifestations of Iron Deficiency Anemia—A Literature Review Eur. Psychiatry 2023 66 S243 S244